# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001564590-20-005550
Filing Date
2020-02-20
Accepted
2020-02-20 16:02:37
Documents
43
Period of Report
2020-02-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | eypt-8k_20200220.htm | 8-K | 35975
2 | EX-99.1 | eypt-ex991_6.htm | EX-99.1 | 38909
3 | GRAPHIC | gvkeammaodsr000001.jpg | GRAPHIC | 281404
4 | GRAPHIC | gvkeammaodsr000023.jpg | GRAPHIC | 297947
5 | GRAPHIC | gvkeammaodsr000036.jpg | GRAPHIC | 242390
6 | GRAPHIC | gvkeammaodsr000035.jpg | GRAPHIC | 280743
7 | GRAPHIC | gvkeammaodsr000026.jpg | GRAPHIC | 354038
8 | GRAPHIC | gvkeammaodsr000015.jpg | GRAPHIC | 262942
9 | GRAPHIC | gvkeammaodsr000012.jpg | GRAPHIC | 283261
10 | GRAPHIC | gvkeammaodsr000029.jpg | GRAPHIC | 256427
11 | GRAPHIC | gvkeammaodsr000028.jpg | GRAPHIC | 241728
12 | GRAPHIC | gvkeammaodsr000039.jpg | GRAPHIC | 212210
13 | GRAPHIC | gvkeammaodsr000017.jpg | GRAPHIC | 314499
14 | GRAPHIC | gvkeammaodsr000025.jpg | GRAPHIC | 346789
15 | GRAPHIC | gvkeammaodsr000034.jpg | GRAPHIC | 243595
16 | GRAPHIC | gvkeammaodsr000022.jpg | GRAPHIC | 154408
17 | GRAPHIC | gvkeammaodsr000021.jpg | GRAPHIC | 166572
18 | GRAPHIC | gvkeammaodsr000003.jpg | GRAPHIC | 362808
19 | GRAPHIC | gvkeammaodsr000010.jpg | GRAPHIC | 359752
20 | GRAPHIC | gvkeammaodsr000033.jpg | GRAPHIC | 251623
21 | GRAPHIC | gvkeammaodsr000031.jpg | GRAPHIC | 272629
22 | GRAPHIC | gvkeammaodsr000024.jpg | GRAPHIC | 320195
23 | GRAPHIC | gvkeammaodsr000027.jpg | GRAPHIC | 109891
24 | GRAPHIC | gvkeammaodsr000041.jpg | GRAPHIC | 362916
25 | GRAPHIC | gvkeammaodsr000016.jpg | GRAPHIC | 223545
26 | GRAPHIC | gvkeammaodsr000018.jpg | GRAPHIC | 243549
27 | GRAPHIC | gvkeammaodsr000013.jpg | GRAPHIC | 231455
28 | GRAPHIC | gvkeammaodsr000040.jpg | GRAPHIC | 351789
29 | GRAPHIC | gvkeammaodsr000020.jpg | GRAPHIC | 144714
30 | GRAPHIC | gvkeammaodsr000004.jpg | GRAPHIC | 221974
31 | GRAPHIC | gvkeammaodsr000011.jpg | GRAPHIC | 252069
32 | GRAPHIC | gvkeammaodsr000032.jpg | GRAPHIC | 198962
33 | GRAPHIC | gvkeammaodsr000002.jpg | GRAPHIC | 789124
34 | GRAPHIC | gvkeammaodsr000007.jpg | GRAPHIC | 211899
35 | GRAPHIC | gvkeammaodsr000038.jpg | GRAPHIC | 217492
36 | GRAPHIC | gvkeammaodsr000019.jpg | GRAPHIC | 199836
37 | GRAPHIC | gvkeammaodsr000009.jpg | GRAPHIC | 315547
38 | GRAPHIC | gvkeammaodsr000037.jpg | GRAPHIC | 260876
39 | GRAPHIC | gvkeammaodsr000008.jpg | GRAPHIC | 332272
40 | GRAPHIC | gvkeammaodsr000030.jpg | GRAPHIC | 216410
41 | GRAPHIC | gvkeammaodsr000006.jpg | GRAPHIC | 253629
42 | GRAPHIC | gvkeammaodsr000014.jpg | GRAPHIC | 300907
43 | GRAPHIC | gvkeammaodsr000005.jpg | GRAPHIC | 244303
| Complete submission text file | 0001564590-20-005550.txt |  | 15488957

Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

EIN.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51122 | Film No.: 20635018
SIC: 3826 Laboratory Analytical Instruments